You just read:

TCR2 Therapeutics to Debut Positive Solid Tumor Data on its Novel TRuC™ Engineered T Cell Platform at the World Preclinical Congress

News provided by

TCR2 Therapeutics

Jun 07, 2017, 10:17 ET